| 1 | [SID103409349] | Unspecified | IC50 | 1090 | Inhibition of NADPH oxidase in human HUVEC assessed as inhibition of superoxide anion generation by cytochrome-C reduction assay [AID436595, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | IC50 | 1090 [uM] | | BioAssay | Inhibition of NADPH oxidase in human HUVEC assessed as inhibition of superoxide anion generation by cytochrome-C reduction assay | | AID | 436595 | | BioAssay type | Literature | | Target | | | PubMed | 19523836 | | Data Table |  |
|
| 2 | [SID103409349] | Unspecified | IC50 | 61000 | Inhibition of p47phox/p22phox interaction by ELISA [AID436598, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | IC50 | 61000 [uM] | | BioAssay | Inhibition of p47phox/p22phox interaction by ELISA | | AID | 436598 | | BioAssay type | Literature | | Target | | | PubMed | 19523836 | | Data Table |  |
|
| 3 | [SID103409349] | Unspecified | | | Ability to protect microvascular damages in ischemia/reperfusion (in vivo) was determined by measuring the inhibition of leaky sites, 30-min after the start of reperfusion at 30 mg/kg [AID87266, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Ability to protect microvascular damages in ischemia/reperfusion (in vivo) was determined by measuring the inhibition of leaky sites, 30-min after the start of reperfusion at 30 mg/kg | | AID | 87266 | | BioAssay type | Literature | | Target | | | PubMed | 12639551 | | Data Table |  |
|
| 4 | [SID103409349] | Unspecified | | | Inhibition of beta-hexosaminidase in anti-DNP IgE sensitized rat RBL2H3 cells at 100 uM after 10 mins [AID333180, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Inhibition of beta-hexosaminidase in anti-DNP IgE sensitized rat RBL2H3 cells at 100 uM after 10 mins | | AID | 333180 | | BioAssay type | Literature | | Target | | | PubMed | 15387643 | | Data Table |  |
|
| 5 | [SID103409349] | Unspecified | | | Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of TNFalpha formation at 30 uM pretreated 1 hr before LPS challenge measured after 24 hrs by enzyme immunoassay [AID360334, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of TNFalpha formation at 30 uM pretreated 1 hr before LPS challenge measured after 24 hrs by enzyme immunoassay | | AID | 360334 | | BioAssay type | Literature | | Target | | | PubMed | 11374953 | | Data Table |  |
|
| 6 | [SID103409349] | Unspecified | | | Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of TNFalpha formation at 30 uM pretreated 1 hr before LPS/IFNgamma challenge measured after 24 hrs by enzyme immunoassay [AID360336, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Antiinflammatory activity in LPS/IFN-gamma-stimulated mouse N9 cells assessed as inhibition of TNFalpha formation at 30 uM pretreated 1 hr before LPS/IFNgamma challenge measured after 24 hrs by enzyme immunoassay | | AID | 360336 | | BioAssay type | Literature | | Target | | | PubMed | 11374953 | | Data Table |  |
|
| 7 | [SID103409349] | Unspecified | | | Antioxidant activity against microvascular damage in hamster model of cheek pouch submitted to ischemia/reperfusion assessed as inhibition of leaky sites at 3 mg/kg treated by gavage route 30 mins before anesthesia measured after 30 mins of reperfusion by FITC-dextran based microscopy [AID430015, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Antioxidant activity against microvascular damage in hamster model of cheek pouch submitted to ischemia/reperfusion assessed as inhibition of leaky sites at 3 mg/kg treated by gavage route 30 mins before anesthesia measured after 30 mins of reperfusion by FITC-dextran based microscopy | | AID | 430015 | | BioAssay type | Literature | | Target | | | PubMed | 19477651 | | Data Table |  |
|
| 8 | [SID103409349] | Unspecified | | | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs [AID462333, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs | | AID | 462333 | | BioAssay type | Literature | | Target | | | PubMed | 20189399 | | Data Table |  |
|
| 9 | [SID103409349] | Unspecified | | | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs [AID462334, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs | | AID | 462334 | | BioAssay type | Literature | | Target | | | PubMed | 20189399 | | Data Table |  |
|
| 10 | [SID103409349] | Unspecified | | | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs [AID462335, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs | | AID | 462335 | | BioAssay type | Literature | | Target | | | PubMed | 20189399 | | Data Table |  |
|
| 11 | [SID103409349] | Unspecified | | | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs [AID462336, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs | | AID | 462336 | | BioAssay type | Literature | | Target | | | PubMed | 20189399 | | Data Table |  |
|
| 12 | [SID103409349] | Unspecified | | | Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay [AID462342, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103409349 | | CID | 2214 | | Outcome | Unspecified | | BioAssay | Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay | | AID | 462342 | | BioAssay type | Literature | | Target | | | PubMed | 20189399 | | Data Table |  |
|
| 13 | [SID51088030] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID51088030] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID51088030] | Inactive | Potency | 2.5119 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | 2.5119 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID51088030] | Inactive | Potency | 25.929 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | 25.929 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 17 | [SID51088030] | Inactive | Potency | 89.1251 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 18 | [SID51088030] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 19 | [SID51088030] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 20 | [SID51088030] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 21 | [SID51088030] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 22 | [SID51088030] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 23 | [SID51088030] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 24 | [SID51088030] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 25 | [SID51088030] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 26 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 27 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 28 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 29 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen [AID2810, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen | | AID | 2810 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 30 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen [AID2810, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen | | AID | 2810 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 31 | [SID51088030] | Inactive | | | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen [AID2810, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators for Cherry Picked Compounds from Primary Screen | | AID | 2810 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 32 | [SID51088030] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 33 | [SID51088030] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 34 | [SID51088030] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 35 | [SID51088030] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 36 | [SID51088030] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 37 | [SID51088030] | Inactive | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 38 | [SID51088030] | Inactive | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity [AID504775, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity | | AID | 504775 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 39 | [SID51088030] | Inactive | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 40 | [SID51088030] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4) [AID2227, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4) | | AID | 2227 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 41 | [SID51088030] | Inactive | | | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). [AID2237, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4). | | AID | 2237 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 42 | [SID51088030] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4). [AID2247, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4). | | AID | 2247 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 43 | [SID51088030] | Inactive | | | High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6) [AID2550, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6) | | AID | 2550 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 44 | [SID51088030] | Inactive | | | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) [AID2553, Type: screening] | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6) | | AID | 2553 | | BioAssay type | screening | | Target | short transient receptor potential channel 6 [Mus musculus] [gi:160333370] | | PubMed | | | Data Table |  |
|
| 45 | [SID51088030] | Inactive | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 46 | [SID51088030] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 47 | [SID51088030] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 48 | [SID51088030] | Inactive | | | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity [AID504441, Type: screening] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504441 | | BioAssay type | screening | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 49 | [SID51088030] | Inactive | | | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity [AID504441, Type: screening] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | BioAssay | Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504441 | | BioAssay type | screening | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 50 | [SID51088030] | Inactive | Potency | | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51088030 | | CID | 2214 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|